COPD describes a group of progressive lung conditions characterised by inflammation and airflow obstruction to and from the lungs. Common symptoms of COPD include shortness of breath, a persistent ...

There is a diversity in individual patient needs, and there is no ‘one-size-fits-all’ approach for COPD care and management,” wrote Anke Lenferink, PhD, and coauthors. The authors outlined four ...

Introduction The benefits achieved during pulmonary rehabilitation (PR) are known to decline 6–12 months after the initial programme. There is no consensus on the best maintenance strategy.1 Previous ...

FREDERICTON— A virtual chronic disease management program for people with asthma and chronic obstructive pulmonary disease (COPD) officially launched in Atlantic Canada this week. The company, ...

Viz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered workflow solution for improving the management of chronic obstructive ...

Background: Chronic obstructive pulmonary disease (COPD) is a prevalent disease that is frequently treated in primary care. However, data regarding the primary care management of COPD are scarce ...

For patients with COPD, implementation of a chronic disease management program through accredited disease-specific clinics was linked with reduced all-cause ED visits, according to a study published ...

Lange et al. studied a group of 6628 individuals with COPD who were followed over an average period of 4.3 years regarding COPD exacerbations, hospital admissions, and mortality.

Sanofi (ENXTPA:SAN) recently entered into a multi-year partnership with Viz.ai and Regeneron to develop an AI-powered solution for COPD management, reflecting its focus on innovation. Over the ...